Concluding Remarks: Optimal Treatment for Women With Ovarian Cancer

Edward L. Trimble

doi:10.1053/j.seminoncol.2006.11.004

Concluding Remarks: Optimal Treatment for Women With Ovarian Cancer

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	25-26
Number of pages	2
Journal	Seminars in oncology
Volume	33
Issue number	SUPPL. 12
DOIs	https://doi.org/10.1053/j.seminoncol.2006.11.004
State	Published - Dec 2006
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1053/j.seminoncol.2006.11.004

Cite this

@article{5e53a1c0417e407bb550b4e077427a39,

title = "Concluding Remarks: Optimal Treatment for Women With Ovarian Cancer",

author = "Trimble, {Edward L.}",

note = "Funding Information: This activity is supported by an unrestricted educational grant from MedImmune Oncology, Inc., a subsidiary of MedImmune, Inc. ",

year = "2006",

month = dec,

doi = "10.1053/j.seminoncol.2006.11.004",

language = "English (US)",

volume = "33",

pages = "25--26",

journal = "Seminars in Oncology",

issn = "0093-7754",

publisher = "W.B. Saunders Ltd",

number = "SUPPL. 12",

}

TY - JOUR

T1 - Concluding Remarks

T2 - Optimal Treatment for Women With Ovarian Cancer

AU - Trimble, Edward L.

N1 - Funding Information: This activity is supported by an unrestricted educational grant from MedImmune Oncology, Inc., a subsidiary of MedImmune, Inc.

PY - 2006/12

Y1 - 2006/12

UR - http://www.scopus.com/inward/record.url?scp=33846077653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846077653&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2006.11.004

DO - 10.1053/j.seminoncol.2006.11.004

M3 - Article

C2 - 17223447

AN - SCOPUS:33846077653

VL - 33

SP - 25

EP - 26

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - SUPPL. 12

ER -

Concluding Remarks: Optimal Treatment for Women With Ovarian Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this